ABSTRACT -Context:P r i m a ry central nervous system lymphomas (PCNSL) are a rare subgroup of lymphomas generally associated with HIV and EBV. Objective: To study ten autopsy cases of PCNSL, to describe the n e u ropathological findings, to characterize the phenotype of the neoplastic cells, to detect EBV in the lesion and to compare the findings with the clinical and laboratory data of the patients. Method: T h e clinical, histological and immunohistochemical data of ten cases of PCNSL, eight cases from patients with AIDS, identified among 265 autopsies of these patients were analyzed. Results: Seven patients were males and the mean age was 40.9 years. The most frequent symptomatology was focal neurologic deficit (70%). Six patients presented with only one lesion. Histologically, densely cellular and polymorphous neoplasms with angiocentrism were observed, in 90% of cases. An association with other diseases was observed in four cases. Most patients had diffuse large B cell non-Hodgkin's lymphoma. EBV was detected by immunohistochemistry in only one case. The lack of detection of the virus might have been due to the long time of fixation of the brain which might have inactivate epitopes there f o re compromising the testing. Conclusion: In the present series, PCNSL presented with focal symptoms, with unifocal or multifocal lesions, with a predominant B-cell CD20 positive phenotype, rarely associated with EBV.
P r i m a ry central nervous system lymphomas (PCN S L ) a re a rare group of neoplasms, accounting for about 0.3 to 1.5% of all intracranial tumors and for 0.7 to 2% of lymphomas 1 . These tumors are generally associated with immunosuppression due to either the use of immunosuppressive dru g s 2 , human immunodeficiency virus (HIV) infection 3 , 4 or congenital disord e r s such as Wiskott-Aldrich syndro m e 5 . PCNSL differ fro m extranodal lymphomas in terms of patient surv i v a l , p redisposing factors, histological subtypes and diff i-culties in the classification according to the Wo r k i n g F o rmulation, the Kiel criteria and the revised European-American Lymphoma (REAL) system. In view of their restriction to a non-lymphoid organ, among other reasons, PCNSL have been considered a separate entity whose prognosis is generally worse than that of systemic lymphomas 6 . With the advent of AIDS and the introduction of organ transplants, the incidence of PCNSL has been increasing. These tumors c u rrently re p resent an important subgroup of lymphomas 2, 4 . In patients with AIDS, PCNSL are the second most common lesion with a mass eff e c t 4 and the most frequent noninfectious cause of death 7 . The tumor re p resents the fourth cause of death in this g roup of patients 8 . PCNSL show a male/female ratio of 1.5 to 1, whereas the T subtype presents a ratio of 7 : 1 9 . The clinical manifestations are indistinguishable f rom cerebral toxoplasmosis and include loss of consciousness and focal neurologic deficits 1 0 . In the case of meningeal involvement, the tumor manifests as a meningeal syndro m e 1 1 , 1 2 . Most PCNSL involve the basal nuclei or the frontal and parietal lobes, and pre sent as homogenous mass lesions with ring-like zone of contrast enhancement and perilesional edema. The neuroimaging diff e rential diagnosis with cerebral toxoplasmosis is difficult 10 . The lesions are multifocal, bilateral or periventricular and may extend to the subarachnoid space or ventricular cavity 1 3 . The m a c roscopic findings are variable 1 4 . Some tumors present as well-defined masses with a homogenous cut s u rface. Other lesions are poorly demarcated, diffusely infiltrating, showing areas of softening, hemo rrhage and necro s i s 1 5 . In immunocompetent patients, PCNSL are more superficial and located in the white and/or gray matter 1 6 , or exclusively in the subarachnoid space 17 . The histopathological findings of PCNSL are similar to those of systemic non-Hodgkin's lymphomas and include densely cellular lesions comprised by atypical lymphoid cells 1 3 with an angiocentric pattern at the margins of the infiltrate and a rich reticulin network dissociating the vascular wall 1 8 . In voluminous tumors, the areas of necrosis can be extensive. Mitotic activity is high and hemorrhage is common. Neoplastic cells may invade normal adjacent s t ru c t u res. There f o re subependymal infiltration extending into the ventricular cavity and subarachnoid space are not uncommon 1 4 . The oncogenesis of PCNSL is still controversial. The site of origin of these lymphomas and the oncogenetic mechanisms are still u n c l e a r, especially because the tumor develops fro m and is restricted to a non-lymphoid organ without lymphatic vessels 19 . It might occur due to the development of a monoclonal proliferation from a preexisting inflammatory lesion, similar to the mechanism underlying the origin of MALT lymphoma fro m Helicobacter pylori-induced gastritis. This hypothesis is supported by the demonstration of inflammat o ry lesions preceding the development of PCNSL 2 0 , 2 1 . Other authors suggest that non-neoplastic lymphocytes might be targeted to the CNS by a viral infection, more notably HTLV-1 or EBV, with the possible later occurrence of clonal neoplastic transform a t i o n of these cells 12 . In the case of immunodepressed patients, one may speculate that the lack of control of T cells over EBV present in patients with AIDS promotes the reactivation of EBV infection, leading to the proliferation of B cells, induction of oncogenes and gene re a rrangements, and finally to the development of PCNSL 2 2 . There f o re in patients with AIDS, infection with EBV is suggested to be the most likely oncogenetic mechanisms since the EBV genome is found in more than 95% of these tumors and in less of 20% of PCNSL not associated with AIDS 2 3 -2 5 . Herpes v i rus genomes such as HHV-6 or HHV-8 have been identified in some cases, suggesting that these or other herpes viruses may predispose to the development of primary lymphoma, even in immunocompetent patients 2 3 . HIV-infected subjects show a 60 to 100 times higher risk of developing malignant lymphoma, which re p resents a diagnostic criterion for AIDS 5 . Based on the above observations, we studied ten autopsy cases of PCNSL to more accurately describe the neuropathological findings and to characterize the phenotype of the neoplastic cells, to test the pre sence of EBV and to compare the morphological findings with the clinical and laboratory data of the patients.
METHOD
A total of 265 autops ies of patients perf o rmed at the S e rvice of Pathological Anatomy, Department of Pathology, Antônio Pedro University Hospital, Federal University Fluminense, between 1987 and 1996 were revised and 10 cases of PCNSL were selected (3.7%).
P reparation of the material and fixation -
The autopsy was complete in all cases and the CNS was fixed in 30% f o rmalin for 21 days and then examined. The cerebral hemis p h e res were studied in approximately 1.0-cm thick coronal sections and in 0.5-to 1.0-cm perpendicular sections cut from the cerebral trunk and cerebellar hemispheres.
Fragments re p resentative of the lesions were embedded in paraffin, cut into 5-µm thick sections, stained with hematoxylin-eosin and for reticulin fibers.
I m m u n o h i s t o c h e m i s t ry-5 -µm thick CNS sections were
mounted on slides previously treated with 3-aminopropyltriethoxysilane (Sigma, A3648). After incubation in an oven at 60ºC for about 18 h, the sections were deparaffinized in xylene and hydrated in decreasing ethanol concentrations. Next, the specimens were incubated in two baths of 3% oxygenated water in methanol for 15 min each to inhibit endogenous peroxidase and washed with Tris buff e r, pH 7.4. For antigen retrieval, the sections were immersed in citrate buff e r, pH 6.0, and heated in a microwave oven for 5 min at maximum potency. Pre s s u re chamber was used to CD3, CD20, CD15, KAPPA, LAMBDA e EBV antibodies. To inhibit nonspecific binding, the sections were incubated in a Tr i s -b u ff e red solution of 1% skim milk (w/v) and 1% bovine serum albumin (w/v) in a humid chamber for 1 h at room temperature. Next, the sections were incubated overnight in a humid chamber at 4ºC with the following prim a ry antibodies: rabbit anti-human CD3 polyclonal (Dako, A 0452, diluted 1/200), mouse anti-human CD20 monoclonal (Dako, M 0755, diluted 1/250), mouse anti-human CD15 (Dako, M 733, diluted 1/150), mouse anti-human Kappa monoclonal (Sigma, K-4377, diluted 1/4000), mouse antihuman Lambda monoclonal (Sigma, L-6522, diluted 1/4000), and mouse anti-EBV monoclonal (Dako, M 0897, diluted 1/2500).
For the anti-CD30, anti-CMV and anti-GFAP antibodies, the sections were trypsinized, nonspecific binding of the antibodies was blocked and the specimens w ere incubated in a humid chamber at 37ºC with the following primary antibodies: mouse anti-human CD30 monoclonal antibody (Dako, M 751, diluted 1/100), mouse anti-CMV monoclonal antibody (Dako, M 854, diluted 1/100), and rabbit anti-GFAP polyclonal antibody (Dako, Z 0334, diluted 1/400).
Next, the sections were washed three times in Tris buff e r for 10 min each and incubated with the biotinylated seco n d a ry antibodies: goat anti-rabbit immunoglobulins (Dako, E 432, diluted 1/200) or rabbit anti-mouse immunoglobulins (Dako, E 0354, diluted 1/200) for 1 h in a humid chamber at 37ºC. The primary and secondary antibodies were diluted in Tr i s -b u ff e red 1% bovine serum albumin (w/v). After three washes in Tris buffer for 10 min each, the sec-
The sections were counterstained with Mayer's hematoxylin. The antibodies used are shown in Table 1 .
RESULTS

General clinical data and laboratory exams -
T h e g e n d e r, age, risk behavior, clinical data and complem e n t a ry exams of the patients are summarized in Table 2. Seven patients were males and three were females, with age ranging from 24 to 64 years (mean ±s t a n d a rddeviation: 40.9±11.8 years). Neuro l o g i c a l signs or symptoms were observed in all but one case, with a predominance of focal neurological deficit in seven patients. The time between the discovery of HIV positivity and the diagnosis of PCNSL ranged fro m 6 months to 3 years.
G ross findings -B rown-grayish, poorly demarc a ted lesions with areas of necrosis, comprised by soft, fleshy to friable tissue, were identified in the basal nuclei (Fig 1) and thalamus of six, in the cere b r a l t runk of four, in the cerebellar hemisphere of thre e , and in the cortex and corpus callosum of two patients. Multiple lesions were observed in six cases, with the number of lesions ranging from 2 to 4. In three cases, only one lesion was identified.
In one case, the gross findings diff e red from those observed in other cases. The tumor lesion was characterized by a whitish color and homogenous surf ace with a fish-flesh appearance, and involved stru ct u res of the midline and deep gray matter, extending to the corpus callosum and adjacent white matter (Fig 2) . Another case was characterized by the e n l a rgement of the nerve roots and cranial nerv e s , and opacity of the leptomeninges. Analysis of the 978 Arq Neuropsiquiatr 2006;64(4) various sections did not reveal any pare n c h y m a l abnormalities.
Other important associated macroscopic findings w e re cortical atrophy in four cases and cerebral edema accompanied by uncal and tonsillar herniation in two (Table 3) .
M i c roscopic findings -M i c roscopic examination revealed densely cellular parenchymatous lesions in nine cases (Fig 3A) . These lesions were characterized by atypical lymphoid cells, a central area of necrosis and an angiocentric pattern at the periphery of the infiltrate (Fig 3B) , with a rich reticulin network dissociating the vascular wall. Only one case did not present the angiocentric arrangement.
In most cases, infiltration was diffuse and consisted of a polymorphic infiltrate comprised pre d o m i n a ntly by large, sometimes bi-or multinucleated, immunoblast-like cells containing large, pleomorphic, vesicular nuclei, clearly visible nucleoli and scarce cytoplasm. The mitotic count was high. In two cases the cellular infiltration was made up by small lymphoid cells with inconspicuous mitotic activity. Plasma cell diff e re n t iation was also observed in one case (Table 4) .
Gliosis was identified in all cases, especially at the p e r i p h e ry of the tumoral mass, and reactive astro c ytes were eventually observed within the tumor tissue.
Associated disorders -O p p o rtunistic infections w e re observed in six cases: HIV-encephalitis (n=2), CMV -encephalitis (n=2), cerebral toxoplasmosis (n=1) and cerebral cryptococcosis (n=1) ( Table 4) .
Immunohistochemical findings -All cases but one showed a B phenotype (CD20 positive); the remaining case, from a HIV negative patient, was positive for T-lymphocytes (CD3 positive). In addition, just one case was CD30 positive and one case EBV positive (Fig 4) .
According to the REAL classification 26 , three cases were classified as diffuse large B-cell non-Hodgkin's lymphoma, one case as lymphoplasmacytic non-Hodg k i n 's lymphoma, one case as B-lymphoblast pre c u rsor non-Hodgkin's lymphoma, and one case as peripheral T-cell non-Hodgkin's lymphoma, not otherw i s e specified. The three cases, in which no immunohist o c h e m i s t ry could be perf o rmed, were classified as probably diffuse large B-cell lymphoma. 
DISCUSSION
In the present study, all tumors were only identified in the CNS, in agreement with the criteria for the diagnosis of PCNSL which re q u i re that no lymphomas are detected in organs other than the CNS or posterior region of the retina at the onset of neurological symptoms 11, 14 . By definition, extranodal lymphomas are recognized as lymphoid tumors arising f rom lymphoid cell-containing sites other than the lymph nodes 27 .
M a c ro s c o p i c a l l y, the lesions were similar to those of toxoplasmosis, a finding also re p o rted by Cirilo and Rosenblum 1 5 . Similarly, neuroimaging does not p e rmit a diff e rential diagnosis with cerebral toxop l a s m o s i s 4 and other methods are necessary for diagnosis conclusion 2 8 . Thus, in the present study, the diagnosis of PCNSL was made only by microscopy.
In the present study, immunohistochemistry for EBV revealed only one positive case in an AIDS patient. The lack of detection of the virus might have been due to the long time of fixation of the brain which might have inactivate epitopes there f o re compromising the testing.
Association with other CNS disorders was a frequent finding in the present series. It might be speculated as proposed by Aderson et al.
2 0 and Aozasa et al. 2 1 that the presence of HIV-or CMV-induced encephalitis is responsible for B-cell hyperreactivity.
PCNSL continue to be a challenge in terms of their morphology and oncogenesis. Molecular studies of oncogenes and suppressor genes are still inconclusive. These lymphomas develop in non-lymphoid organs without lymphatic vessels, and as such re p resent one of the main areas of neuro-oncological research.
